Differential Regulation of the Human κ Opioid Receptor by Agonists: Etorphine and Levorphanol Reduced Dynorphin A- and U50,488H-Induced Internalization and Phosphorylation
- 24 January 2003
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in The Journal of pharmacology and experimental therapeutics
- Vol. 305 (2), 531-540
- https://doi.org/10.1124/jpet.102.045559
Abstract
We previously observed that (trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide (U50,488H) promoted internalization and phosphorylation of the FLAG-tagged human κ opioid receptor (FLAG-hkor) stably expressed in Chinese hamster ovary (CHO) cells. In this study, we compared regulation of the FLAG-hkor expressed in CHO cells by U50,488H, dynorphin A, etorphine, and levorphanol, which were potent full agonists as determined by stimulation of guanosine 5′-O-(3-[35S]thio)triphosphate binding. Using fluorescence flow cytometry, we found that dynorphin A(1-17), like U50,488H, promoted internalization of the FLAG-hkor in a time- and dose-dependent manner. The antagonists naloxone and norbinaltorphimine, having no effect on FLAG-hkor internalization, effectively blocked dynorphin A(1-17)- and U50,488H-induced internalization. Interestingly, the full agonists etorphine and levorphanol did not cause internalization of the FLAG-hkor but significantly reduced dynorphin A(1-17)- and U50,488H-induced internalization in a dose-dependent manner. Immunofluorescence staining of FLAG-hkor yielded similar results. Dynorphin A(1-17) and U50,488H enhanced phosphorylation of FLAG-hkor to a greater extent than etorphine, but levorphanol did not increase FLAG-hkor phosphorylation. Etorphine or levorphanol decreased dynorphin- or U50,488H-induced phosphorylation. It is likely that conformations of the hkor required for phosphorylation and initiation of internalization are different from those for activation of G proteins. We also examined whether the four agonists had differential effects on superactivation of adenylate cyclase. Pretreatment with U50,488H, dynorphin A(1-17), or etorphine enhanced forskolin-stimulated adenylate cyclase activity to ∼200 to 250% of the control, whereas levorphanol pretreatment did not result in significant adenylate cyclase superactivation. Thus, the degree of superactivation caused by an agonist is unrelated to its ability to promote internalization of the hkor.Keywords
This publication has 38 references indexed in Scilit:
- Seven-transmembrane receptorsNature Reviews Molecular Cell Biology, 2002
- Visualizing Preference of G Protein-Coupled Receptor Kinase 3 for the Process of κ-Opioid Receptor SequestrationMolecular Pharmacology, 2002
- Regulation of Opioid Receptor Trafficking and Morphine Tolerance by Receptor OligomerizationCell, 2002
- A Transplantable Sorting Signal That Is Sufficient to Mediate Rapid Recycling of G Protein-coupled ReceptorsPublished by Elsevier BV ,2001
- Agonist‐Induced Phosphorylation of the κ‐Opioid ReceptorJournal of Neurochemistry, 1997
- δ and κ Opioid Receptors Are Differentially Regulated by Dynamin-dependent Endocytosis When Activated by the Same Alkaloid AgonistPublished by Elsevier BV ,1997
- Differential Agonist Regulation of the Human κ‐Opioid ReceptorJournal of Neurochemistry, 1997
- Recent advances in molecular recognition and signal transduction of active peptides: Receptors for opioid peptidesCellular and Molecular Neurobiology, 1995
- κ-Opioid receptor-transfected cell lines: modulation of adenylyl cyclase activity following acute and chronic opioid treatmentsFEBS Letters, 1995
- Anatomy of CNS opioid receptorsTrends in Neurosciences, 1988